• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926028250
Medical Device Problem Code Bent (1059)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 05/26/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).Device evaluated by mfr.: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the mildly tortuous and calcified left anterior descending artery.A 2.50 x 28mm synergy ii drug-eluting stent (des) was advanced to treat the lesion.However, the device was unable to cross and it was noted that the distal end of the stent was damaged.A 2.50 x 15mm emerge balloon catheter was then advanced to pre-dilate the lesion and the procedure was completed with another 2.50 x 28mm synergy ii des.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the synergy ii us mr 2.50 x 28 mm stent delivery system was returned for analysis.A visual examination of the stent found that on the proximal stent strut row 4, a stent strut was lifted.The undamaged section crimped stent maximum outer diameter measurement was within the maximum crimped stent profile measurement.Stent damage most likely occurred during withdrawal attempts.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.The tip was visually and microscopically examined and signs of damage were noted at the distal edges of the tip.This type of damage most likely occurred when the tip was pushed against a restriction.A visual and tactile examination found multiple kinks along several locations of the hypotube shaft.This type of damage is consistent with excessive force being applied on the delivery system.A visual and tactile examination of the outer and the inner lumen and mid-shaft section found no issues with the shaft polymer extrusion.The bi-component bond showed no signs of damage or strain.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is operational context as the product meets the design & manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the mildly tortuous and calcified left anterior descending artery.A 2.50 x 28mm synergy ii drug-eluting stent (des) was advanced to treat the lesion.However, the device was unable to cross and it was noted that the distal end of the stent was damaged.A 2.50 x 15mm emerge balloon catheter was then advanced to pre-dilate the lesion and the procedure was completed with another 2.50 x 28mm synergy ii des.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7612093
Report Number2134265-2018-05484
Device Sequence Number2222203
Product Code NIQ
UDI-Device Identifier08714729840275
UDI-Public08714729840275
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/16/2019
Device Model NumberH7493926028250
Device Catalogue Number39260-2825
Device Lot Number21646435
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/12/2018
Initial Date Received by Manufacturer 05/30/2018
Supplement Date Received by Manufacturer08/02/2018
Initial Report FDA Received Date06/18/2018
Supplement Report FDA Received Date08/17/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age65 YR
-
-